Evolocumab in Patients with Cardiovascular Disease

Marc S Sabatine^{1

2}, Robert P Giugliano¹, Terje R Pedersen³

Affiliations

Free article

Comment

Marc S Sabatine et al. N Engl J Med. 2017.

Free article

. 2017 Aug 24;377(8):787-8.

doi: 10.1056/NEJMc1708587.

Marc S Sabatine^{1

2}, Robert P Giugliano¹, Terje R Pedersen³

No abstract available

Comment on

Evolocumab in Patients with Cardiovascular Disease.
Koskinas KC, Windecker S. Koskinas KC, et al. N Engl J Med. 2017 Aug 24;377(8):786. doi: 10.1056/NEJMc1708587. N Engl J Med. 2017. PMID: 28834472 No abstract available.
Evolocumab in Patients with Cardiovascular Disease.
Nunes JPL. Nunes JPL. N Engl J Med. 2017 Aug 24;377(8):787. doi: 10.1056/NEJMc1708587. N Engl J Med. 2017. PMID: 28834473 No abstract available.
Evolocumab in Patients with Cardiovascular Disease.
García de Tena J, Morales-Ortega A, Pindao-Quesada G. García de Tena J, et al. N Engl J Med. 2017 Aug 24;377(8):785. doi: 10.1056/NEJMc1708587. N Engl J Med. 2017. PMID: 28836418 No abstract available.
Evolocumab in Patients with Cardiovascular Disease.
Naci H, Mehra MR. Naci H, et al. N Engl J Med. 2017 Aug 24;377(8):785-6. doi: 10.1056/NEJMc1708587. N Engl J Med. 2017. PMID: 28836419 No abstract available.
Evolocumab in Patients with Cardiovascular Disease.
Redberg RF, Prasad V. Redberg RF, et al. N Engl J Med. 2017 Aug 24;377(8):786-7. doi: 10.1056/NEJMc1708587. N Engl J Med. 2017. PMID: 28836420 No abstract available.